[{"Assets_0_Q3_USD":4493100000.0,"EarningsPerShareDiluted_1_Q3_USD":0.22,"EarningsPerShareDiluted_3_Q3_USD":0.46,"EarningsPerShareBasic_3_Q3_USD":0.46,"EarningsPerShareBasic_1_Q3_USD":0.22,"StockholdersEquityConverted_0_Q3_USD":1620700000.0,"StockholdersEquity_0_Q3_USD":1620700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":143896635.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":145145310.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":145593210.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":146758271.0,"NetIncomeLossConverted_3_Q3_USD":66300000.0,"NetIncomeLossConverted_1_Q3_USD":31700000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":159800000.0,"CommonStockSharesOutstanding_0_Q3_shares":145221009.0,"CommonStockSharesConverted_0_Q3_shares":145221009.0,"RevenuesConverted_3_Q3_USD":1792300000.0,"RevenuesConverted_1_Q3_USD":617500000.0,"Ticker":"CTLT","CIK":"1596783","name":"CATALENT, INC.","OfficialName":"Catalent Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17076283108.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20190507"}]